New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis

<b>Background:</b> Histone deacetylases (HDACs) are critical epigenetic modulators involved in regulating various molecular mechanisms essential for cell development and growth. Alterations in HDAC activity have been linked to the progression of numerous cancers, including lymphoma. Over the past de...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pavel Spirin, Valeria Vedernikova, Tatsiana Volkava, Alexey Morozov, Alla Kleymenova, Anastasia Zemskaya, Lena Shyrokova, Yuri Porozov, Ksenia Glumakova, Timofey Lebedev, Maxim Kozlov, Vladimir Prassolov
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-03-01
Colecção:	Pharmaceutics
Assuntos:	epigenetic HDACs belinostat lymphoma leukemia apoptosis
Acesso em linha:	https://www.mdpi.com/1999-4923/17/4/416
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!